FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1286411000001100: Co-amilozide 5mg/50mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21466501000001119 Co-amilozide 5mg/50mg tablets 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21466601000001115 Co-amilozide 5mg/50mg tablets 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-amilozide 5mg/50mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets 30 tablet Is pack of Product containing precisely amiloride hydrochloride 5 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets 30 tablet Has active ingredient Amiloride hydrochloride false Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets 30 tablet Has active ingredient Hydrochlorothiazide false Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets 30 tablet Has VMP Product containing precisely amiloride hydrochloride 5 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets 30 tablet Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets 30 tablet Has specific active ingredient Amiloride hydrochloride true Inferred relationship Existential restriction modifier
Co-amilozide 5mg/50mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Amil-Co 5mg/50mg tablets (IVAX Pharmaceuticals UK Ltd) 30 tablet 2 x 15 tablets Is a True Co-amilozide 5mg/50mg tablets 30 tablet Inferred relationship Existential restriction modifier
Moduretic 5mg/50mg tablets (PI) (Waymade Ltd) 30 tablet 3 x 10 tablets Is a True Co-amilozide 5mg/50mg tablets 30 tablet Inferred relationship Existential restriction modifier
Moduretic 5mg/50mg tablets (PI) (Dowelhurst Ltd) 30 tablet Is a True Co-amilozide 5mg/50mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start